These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34453296)

  • 1. Rita Levi-Montalcini, NGF Metabolism in Health and in the Alzheimer's Pathology.
    Cuello AC
    Adv Exp Med Biol; 2021; 1331():119-144. PubMed ID: 34453296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome.
    Iulita MF; Caraci F; Cuello AC
    CNS Neurol Disord Drug Targets; 2016; 15(4):434-47. PubMed ID: 26996175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
    Pentz R; Iulita MF; Ducatenzeiler A; Videla L; Benejam B; Carmona‐Iragui M; Blesa R; Lleó A; Fortea J; Cuello AC
    Alzheimers Dement; 2021 Apr; 17(4):605-617. PubMed ID: 33226181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy.
    Do Carmo S; Kannel B; Cuello AC
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease.
    Iulita MF; Cuello AC
    Curr Alzheimer Res; 2016; 13(1):53-67. PubMed ID: 26391047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides, NGF, brain aging and disease: a mini-review with personal reflections.
    Cuello AC
    Neurochem Res; 2012 Jun; 37(6):1256-60. PubMed ID: 22484968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease.
    Pentz R; Iulita MF; Ducatenzeiler A; Bennett DA; Cuello AC
    Mol Psychiatry; 2021 Oct; 26(10):6023-6037. PubMed ID: 32488129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
    Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
    Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NGF Metabolic Pathway: New Opportunities for Biomarker Research and Drug Target Discovery : NGF Pathway Biomarkers and Drug Targets.
    Pentz R; Iulita MF
    Adv Exp Med Biol; 2021; 1331():31-48. PubMed ID: 34453291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve Growth Factor Compromise in Down Syndrome.
    Do Carmo S; Kannel B; Cuello AC
    Front Aging Neurosci; 2021; 13():719507. PubMed ID: 34434101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.
    Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome.
    Iulita MF; Cuello AC
    Trends Pharmacol Sci; 2014 Jul; 35(7):338-48. PubMed ID: 24962069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor metabolic dysfunction in Down's syndrome brains.
    Iulita MF; Do Carmo S; Ower AK; Fortress AM; Flores Aguilar L; Hanna M; Wisniewski T; Granholm AC; Buhusi M; Busciglio J; Cuello AC
    Brain; 2014 Mar; 137(Pt 3):860-72. PubMed ID: 24519975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype.
    Allard S; Leon WC; Pakavathkumar P; Bruno MA; Ribeiro-da-Silva A; Cuello AC
    J Neurosci; 2012 Feb; 32(6):2002-12. PubMed ID: 22323714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.
    Cuello AC; Bruno MA; Allard S; Leon W; Iulita MF
    J Mol Neurosci; 2010 Jan; 40(1-2):230-5. PubMed ID: 19680822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brain NGF Metabolic Pathway in Health and in Alzheimer's Pathology.
    Cuello AC; Pentz R; Hall H
    Front Neurosci; 2019; 13():62. PubMed ID: 30809111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease.
    Cuello AC; Bruno MA
    Neurochem Res; 2007 Jun; 32(6):1041-5. PubMed ID: 17404842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.
    Cuello AC; Bruno MA; Bell KF
    Curr Alzheimer Res; 2007 Sep; 4(4):351-8. PubMed ID: 17908036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
    Pentz R; Iulita MF; Mikutra-Cencora M; Ducatenzeiler A; Bennett DA; Cuello AC
    Neurobiol Dis; 2021 Jan; 148():105150. PubMed ID: 33130223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
    Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.